The total return over the past 12 months is +53.13% vs. +16.94% for the S&P 500. So far it's up -42.60% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +53.13% | (26.97%) | (46.70%) | N/A | N/A | N/A |
| Total Return CAGR | +53.13% | (26.97%) | (46.70%) | N/A | N/A | N/A |
| Revenue CAGR | +306.42% | N/A | +9.95% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Rani Therapeutics Holdings, Inc. (RANI)
| Year | Start price | End price | RANI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.35 | $0.77 | (42.60%) | +14.51% | (57.11%) |
| 2025 | $1.37 | $1.35 | (1.46%) | +17.72% | (19.18%) |
| 2024 | $3.32 | $1.37 | (58.73%) | +24.89% | (83.62%) |
| 2023 | $5.90 | $3.32 | (43.73%) | +26.19% | (69.92%) |
| 2022 | $16.35 | $5.90 | (63.91%) | (18.17%) | (45.74%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
